AnGes Inc - Company Profile
Powered by 
All the data and insights you need on AnGes Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date AnGes Inc Strategy Report
- Understand AnGes Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View up-to-date information on AnGes Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 10 May 2022 | Eiger BioPharma and AnGes Enter into Agreement | Partnership | - |
AnGes Inc
Eiger BioPharmaceuticals Inc
|
| 22 Dec 2021 | Emendo Biotherapeutics (EmendoBio) and Seattle Children’s Research Institute Enter into Research Collaboration | Partnership | - |
Seattle Children’s Research Institute
EmendoBio Inc
|
| 15 Dec 2020 | AnGes Acquires EmendoBio | Acquisition |
AnGes Inc
|
EmendoBio Inc
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer